Moderna Covid-19 boosters after five-month interval: U.S. FDA
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
It is a novel oral NLRP3 inflammasome inhibitor
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Key takeaways of recent quarter & conference call highlights
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The first clinical trial is expected to commence in early 2022 both in Europe and the US
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
Subscribe To Our Newsletter & Stay Updated